| Trade Name | KYORIN Pharmaceutical Co., Ltd. |
|---|---|
| Main Business | Manufacture, sales, etc., of pharmaceuticals |
| Location of Head Quarter | 1-3-7, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan |
| Telephone | 03-6374-9700 |
| Founding | 1923 |
| Paid-in Capital | 700 million yen |
| Listing | Tokyo Stock Exchange |
Board of Directors and Corporate Auditors
| Representative Director, President and Chief Executive Officer |
Yutaka Ogihara |
|---|---|
| Executive Director, Managing Corporate Officer, CFO & CStO, Director of Corporate Planning |
Yasuji Kurose |
| Executive Director, Managing Corporate Officer, CCO, Senior Director of Sales & Marketing HQs |
Noriaki Tamura |
| Executive Director(outside) | Ken Shigematsu Hiromi Watanabe Tomohiro Okanoya |
| Audit & Supervisory Board Member | Kenji Akutsu Katsuhiro Hamada |
| Audit & Supervisory Board Member (outside) | Takao Yamaguchi Kensuke Morita Yutaka Abe |
Corporate Officer
| Managing Corporate Officer CBDO, Senior Director of Business Development HQs |
Takaaki Kaji |
|---|---|
| Managing Corporate Officer CSO, Senior Director of Discovery Research HQs |
Junichi Ishiyama |
| Managing Corporate Officer CHRO, Director of General Affairs |
Kiyoo Uehara |
| Managing Corporate Officer CMO, Representative Director, President of KYORIN Pharmaceutical Group Facilities Co., Ltd. |
Kenichi Nakamura |
| Corporate Officer, Director of Innovation Promoting |
Kimiya Masada |
| Corporate Officer, Senior Director of Quality Assurance & Reliability HQs |
Hiroki Usui |
Organization
